Pharmacology of coronary artery bypass grafts.
Spasm of arterial and venous graft conduits can occur both during harvesting and after the graft is connected. Attempts to overcome spasm during harvesting by probing or hydraulic distension can cause structural damage to the graft, which may impair short- and long-term patency. After a coronary artery bypass graft is connected, spasm can cause major problems with myocardial perfusion. To select the best pharmacologic agent to prevent or reverse vasoconstriction in a graft requires an understanding of the reactivity of that particular type of graft to vasoconstrictor and vasodilator agents. The pharmacologic reactivity of venous and arterial graft conduits has been documented through extensive studies of isolated vessels in the organ bath and of in situ grafts in the body. In this review we summarize the current state of knowledge of the reactivity of arterial and venous grafts to vasoconstrictor and vasodilator agents and describe the practical application of this knowledge in the operating room and in the postoperative period.
Rosenfeldt
F L
FL
Cardiac Surgical Research Laboratory, Baker Medical Research Institute and Alfred Hospital, Prahran, Victoria, Australia. frank.rosenfeldt@baker.edu.au
He
G W
GW
Buxton
B F
BF
Angus
J A
JA
D001158:Arteries / Q000637:transplantation; D001808:Blood Vessels / Q000187:drug effects; D001026:Coronary Artery Bypass; D003326:Coronary Circulation / Q000187:drug effects*; D006801:Humans; D008323:Mammary Arteries / Q000187:drug effects / Q000502:physiology / Q000637:transplantation; D012501:Saphenous Vein / Q000187:drug effects / Q000502:physiology / Q000637:transplantation; D014661:Vasoconstriction / Q000187:drug effects*; D014662:Vasoconstrictor Agents / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology
D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents